MeiragtxPlc Share Price Today
(NASDAQ: MGTX)

Name: MeiragtxPlc Share Price Today (NASDAQ: MGTX) - MeiragtxPlc Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

MeiragtxPlc share price is $5.41 & ₹462.37 as on 18 Apr 2025, 2.30 'hrs' IST

$5.41

▲

0.09

(1.69%)

Market is closed - opens 7 PM, 21 Apr 2025

View live MeiragtxPlc share price in Dollar and Rupees. Guide to invest in MeiragtxPlc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in MeiragtxPlc, along with analyst recommendations, forecasts, and comprehensive financials.

MeiragtxPlc share price movements

Today's Low: $5.35
Today's High: $5.77
$5.41
1.11%
Downside
Day's Volatility :7.28%
Upside
6.24%
52 Weeks Low: $3.85
52 Weeks High: $8.75
$5.41
28.84%
Downside
52 Weeks Volatility :56.0%
Upside
38.17%

MeiragtxPlc (MGTX) Returns

Period	Meiragtx Holdings Plc	Sector (Health Care)	Index (Russel 2000)
3 Months	-15.6%	-2.8%	0.0%
6 Months	-9.68%	-11.0%	0.0%
1 Year	6.29%	-1.9%	0.0%
3 Years	-56.75%	-1.5%	-12.9%

MeiragtxPlc (MGTX) Key Statistics

in dollars & INR

Previous Close	$5.32
Open	$5.5
Today's High	$5.77
Today's Low	$5.35
Market Capitalization	$426.6M
Today's Volume	$410.3K
52 Week High	$8.75
52 Week Low	$3.85
Revenue TTM	$33.3M
EBITDA	$-151.4M
Earnings Per Share (EPS)	$-2.12
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-143.48%

How to invest in MeiragtxPlc Stock (MGTX) from India?

It is very easy for Indian residents to invest directly in MeiragtxPlc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the MeiragtxPlc stock in both Indian Rupees (INR) and US Dollars (USD). Search for MeiragtxPlc or MGTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of MeiragtxPlc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of MeiragtxPlc shares which would translate to 0.158 fractional shares of MeiragtxPlc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like MeiragtxPlc, in just a few clicks!

Returns in MeiragtxPlc (MGTX) for Indian investors in Rupees

The MeiragtxPlc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

MeiragtxPlc investment value today

Current value as on today

₹1,08,628

Returns

₹8,628

(+8.63%)

Returns from MeiragtxPlc Stock

₹6,287 (+6.29%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards MeiragtxPlc (MGTX)

-75%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for MeiragtxPlc Stock from India on INDmoney has decreased by -75% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in MeiragtxPlc

Davenport & Company LLC
0.10%

Analyst Recommendation on MeiragtxPlc

Rating

Trend

Buy

90%Buy

9%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for MeiragtxPlc(by analysts ranked 0 to 5 stars)

Analyst Forecast on MeiragtxPlc Stock (MGTX)

What analysts predicted

Upside of 336.23%

Target:

$23.60

Current:

$5.41

Insights on MeiragtxPlc Stock (Ticker Symbol: MGTX)

Price Movement
In the last 1 month, MGTX stock has moved down by -31.5%
Increasing Revenue
Revenue is up for the last 3 quarters, 282.0K → 21.39M (in $), with an average increase of 73.2% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -39.33M → -39.39M (in $), with an average decrease of 0.2% per quarter
MGTX vs ONC (1 yr)
In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 71.6%
MGTX vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 28.9% return, outperforming this stock by 87.5%
Price to Sales
ForMGTX every $1 of sales, investors are willing to pay $11.3, whereas for Beone Medicines Ltd, the investors are paying $6.4 for every $1 of sales.

MeiragtxPlc Technicals Summary

Sell

Neutral

Buy

MeiragtxPlc is currently in a neutral trading position according to technical analysis indicators.

MeiragtxPlc (MGTX) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Meiragtx Holdings Plc	-30.46%	-9.68%	6.29%	-56.75%	-60.19%
Regeneron Pharmaceuticals, Inc.	-17.1%	-41.85%	-37.2%	-21.74%	-0.85%
Beone Medicines Ltd	-13.12%	5.03%	78.34%	40.23%	43.44%
Vertex Pharmaceuticals Incorporated	-4.76%	2.3%	24.05%	71.43%	78.99%
Alnylam Pharmaceuticals, Inc.	-9.09%	-19.67%	62.43%	39.66%	61.91%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Meiragtx Holdings Plc	NA	NA	NA	0.0	-1.43	-0.34	NA	0.87
Regeneron Pharmaceuticals, Inc.	14.68	14.68	0.9	41.18	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.09	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.34	17.96	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.81	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Meiragtx Holdings Plc	Buy	$426.6M	-60.19%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$60.5B	-0.85%	14.68	31.07%
Beone Medicines Ltd	NA	$26.9B	43.44%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$125.7B	78.99%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$30.4B	61.91%	NA	-12.37%

About MeiragtxPlc

MeiraGTx Holdings plc, a clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases; neurodegenerative diseases; and xerostomia. It is also developing AAV-AQP1 in Phase 2 trial for radiation-induced grade 2/3 radiation-induced xerostomia, as well as in Phase ½ trial for Sjogren's syndrome; AAV-GAD in Phase 2 trial for Parkinson's disease; AAV-RPE65 in Phase 2 trial for RPE65-associated retinal dystrophy; and AAV-CNGB3 and AAV-CNGA3, which are both in Phase 2 trial for achromatopsia, as well as offers AAV-AIPL1 for Leber congenital amaurosis (LCA) 4. In addition, the company's products under preclinical development include AAV-RDH12 for retinol dehydrogenase 12 mutation-associated retinal dystrophy; AAV-BBS10 for Bardet-Biedl syndrome (BBS) due to BBS10 mutations; AAV-RetGC for LCA type 1; and AAV-UPF1 for amyotrophic lateral sclerosis, as well as programs for Alzheimer's disease, and wet and dry neovascular age related macular degeneration. Further, it provides riboswitch platform for the delivery of metabolic peptides; and cell therapies for oncology, autoimmune disease, and long term intractable pain. The company has collaborations with Johnson & Johnson Innovative Medicine for the research, development, and commercialization of gene therapies for the treatment of inherited retinal disease; and Hologen Limited for the research, development, manufacture, and commercialization of AAV-GAD investigational gene therapy for the treatment of Parkinson's disease, AAV-BDNF investigational gene therapy for genetic obesity disorders, and other genetic medicines to the central nervous system. MeiraGTx Holdings plc was founded in 2015 and is based in New York, New York.

Organization	MeiragtxPlc
Employees	375
CEO	Dr. Alexandria Forbes Ph.D.
Industry	Health Technology

Management People of MeiragtxPlc

Name	Title
Dr. Alexandria Forbes Ph.D.	CEO, President & Director
Mr. Richard Brian Giroux B.A.	COO & CFO
Dr. Stuart Naylor Ph.D.	Chief Development Officer
Mr. Robert J. Wollin J.D.	General Counsel & Secretary
Dr. Michel Michaelides M.D.	Head of Clinical Ophthalmology
Ms. Christine Elise Sheehy	Senior Vice President of Global Integration
Mr. Tim Randall	Senior Vice President of Risk & Internal Controls
Dr. Robert K. Zeldin M.D.	Chief Medical Officer
Dr. David Rubinstein Ph.D.	Senior Vice President of Business Development

Important FAQs about investing in MGTX Stock from India :

What is MeiragtxPlc share price today?

MeiragtxPlc share price today stands at $5.41, Open: $5.50 ; Previous Close: $5.32 ; High: $5.77 ; Low: $5.35 ; 52 Week High: $8.75 ; 52 Week Low: $3.85.

The stock opens at $5.50, after a previous close of $5.32. The stock reached a daily high of $5.77 and a low of $5.35, with a 52-week high of $8.75 and a 52-week low of $3.85.

Can Indians buy MeiragtxPlc shares?

Yes, Indians can invest in the MeiragtxPlc (MGTX) from India.

With INDmoney, you can buy MeiragtxPlc at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy MeiragtxPlc at zero transaction cost.

How can I buy MeiragtxPlc shares from India?

It is very easy to buy MeiragtxPlc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of MeiragtxPlc (MGTX) be purchased?

Yes, you can buy fractional shares of MeiragtxPlc with INDmoney app.

What are the documents required to start investing in MeiragtxPlc stocks?

To start investing in MeiragtxPlc, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.